NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 200,701 | $873,000 | 0.14% |
| MARATHON CAPITAL MANAGEMENT | 30,000 | $131,000 | 0.12% |
| Advisors Asset Management, Inc. | 583,254 | $4,217,000 | 0.06% |
| Eidelman Virant Capital | 26,796 | $117,000 | 0.06% |
| WMS Partners, LLC | 69,250 | $301,000 | 0.05% |
| Brown Advisory Securities, LLC | 16,000 | $70,000 | 0.03% |
| CROFT-LEOMINSTER INC | 20,000 | $87,000 | 0.02% |
| WEBSTER BANK, N. A. | 19,657 | $86,000 | 0.02% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $109,000 | 0.01% |
| SCOTIA CAPITAL INC. | 18,195 | $79,000 | 0.00% |